Prostate Neoplasms Completed Phase 1 / 2 Trials for Enzalutamide (DB08899)

Also known as: Neoplasm, Prostate / Neoplasms, Prostate / Prostate Neoplasm

IndicationStatusPhase
DBCOND0031071 (Prostate Neoplasms)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01284920A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer PatientsTreatment